Cargando…
An anterior mediastinal lesion in TAFRO syndrome showing complete remission after glucocorticoid and tocilizumab therapy
Thrombocytopenia (T), anasarca (A), myelofibrosis (F), renal dysfunction (R), and organomegaly (O) (TAFRO) syndrome is a variant of multicentric Castleman's disease. We describe here a 57‐year‐old man who presented with persistent fever, pleural effusion, and ascites. He was negative for human...
Autores principales: | Sakashita, Kentaro, Murata, Kengo, Inagaki, Yuji, Oota, Souichi, Takamori, Mikio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970309/ https://www.ncbi.nlm.nih.gov/pubmed/27516889 http://dx.doi.org/10.1002/rcr2.173 |
Ejemplares similares
-
TAFRO syndrome: current perspectives
por: Sakashita, Kentaro, et al.
Publicado: (2018) -
Tocilizumab-resistant TAFRO Syndrome Complicated by Type II Respiratory Failure
por: Aoki, Tatsuya, et al.
Publicado: (2017) -
Thalidomide for tocilizumab-resistant ascites with TAFRO syndrome
por: Tatekawa, Shotaro, et al.
Publicado: (2015) -
Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide
por: Kikuchi, Taku, et al.
Publicado: (2017) -
Membranoproliferative glomerulonephritis-like findings for TAFRO syndrome, associated with an anterior mediastinal tumor: A case report
por: Furuto, Yoshitaka, et al.
Publicado: (2018)